A burst of release of one equivalent of trinitrophenolate observed upon inactivation of human pancreatic ␣-amylase proves the required 1:1 stoichiometry. These are the first mechanism-based inhibitors of this class to be described, and the first mechanism-based inhibitors of any sort for the medically important ␣-amylase. In addition to having potential as therapeutics, compounds of this class should prove useful in subsequent structural and mechanistic studies of these enzymes.Specific inhibitors of glycosidases have proved valuable in a number of applications ranging from mechanistic studies (Legler, 1990;Sinnott, 1990) through their use to study protein glycosylation (Elbein et al., 1984), to possible therapeutic uses such as the control of blood glucose levels via control of the degradation of dietary disaccharides and starch (Truscheit et al., 1981) or control of viral infectivity through interference with normal glycosylation of viral coat proteins (Elbein, 1984;Prasad et al., 1987). A number of naturally occurring reversible glycosidase inhibitors are known such as nojirimycin, castanospermine, swainsonine, and acarbose (Legler, 1990), and these have been subjected to intensive study including the synthesis and testing of a number of analogues. Another class of inhibitors that has been less well studied is that of the covalent, irreversible type, typically affinity labels. These are generally synthetic analogues of sugars containing reactive groups such as epoxides, isothiocyanates and ␣-halocarbonyls as reviewed recently (Legler, 1990;Withers and Aebersold, 1995). Less common are the more selective mechanism-based inhibitors whose efficacy depends upon binding and subsequent enzymatic action to generate a reactive species. These include the conduritol epoxides (Legler, 1968(Legler, , 1970, the quinone methidegenerating glycosides (Halazy et al., 1990;Briggs et al., 1992), and the glycosylmethyl triazenes (Marshall et al., 1980;Sinnott and Smith, 1976). Interestingly, two naturally occurring inhibitors of this class have now been described: the hydroxymethylconduritol epoxide, cyclophellitol (Atsumi et al., 1990;Withers and Umezawa, 1991), isolated from Phellinus sp.; and the putative quinone methide-generating glycoside salicortin, isolated from Salix (Clausen et al., 1990).An additional, relatively recently described class of mechanism-based inhibitor that has proved successful is that of the 2-deoxy-2-fluoro (Withers and Aebersold, 1995;Withers et al., 1987Withers et al., , 1988Withers et al., , 1990. These function as excellent inactivators of retaining glycosidases (glycosidases that hydrolyze the glycosidic linkage with net retention of anomeric configuration) by formation of a stable glycosyl-enzyme intermediate which turns over to product only very slowly. As shown in Scheme 1 for an ␣-glucosidase, the normal mechanism of action of this class of enzyme involves the formation and hydrolysis of a glycosyl-enzyme intermediate with general acid/base catalytic assistance via transition states with subs...